erleada
janssen-cilag international nv - apalutamide - neoplasias prostáticas - terapia endócrina - erleada é indicado:em homens adultos para o tratamento de não metastático resistente à castração câncer de próstata (nmcrpc) que estão em alto risco de desenvolver a doença metastática. em homens adultos para o tratamento de metastático hormônio-sensível câncer de próstata (mhspc) em combinação com terapia de privação de andrógeno (adt).
ferane 35
mabra farmaceutica ltda - acetato de ciproterona, etinilestradiol - androgenos simples
abiraterone accord
accord healthcare s.l.u. - acetato de abiraterona - neoplasias prostáticas - terapia endócrina - abiraterone accord is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicatedthe treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.
abiraterone mylan
mylan ireland limited - acetato de abiraterona - neoplasias prostáticas - endocrine therapy, other hormone antagonists and related agents - abiraterone mylan is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt). the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated. the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.
abiraterone krka
krka, d.d., novo mesto - acetato de abiraterona - neoplasias prostáticas - terapia endócrina - abiraterone krka is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt) (see section 5. 1)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. 1)the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel-based chemotherapy regimen.
acetato de ciproterona+etinilestradiol
brainfarma indÚstria quÍmica e farmacÊutica s.a - acetato de ciproterona, etinilestradiol - estrogenos assocs a outros farmacos exclusive androgenos
acetato de ciproterona+etinilestradiol
indÚstria farmacÊutica melcon do brasil s.a. - acetato de ciproterona, etinilestradiol - estrogenos assocs a outros farmacos exclusive androgenos
diane 35
bayer s.a. - acetato de ciproterona, etinilestradiol - estrogenos assocs a outros farmacos exclusive androgenos
dunia 35
indÚstria farmacÊutica melcon do brasil s.a. - acetato de ciproterona, etinilestradiol - estrogenos assocs a outros farmacos exclusive androgenos
selene
eurofarma laboratÓrios s.a. - etinilestradiol, acetato de ciproterona - estrogenos assocs a outros farmacos exclusive androgenos